These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5551376)

  • 1. Phenomycin, toxicity and distribution.
    Nakamura S; Takeuchi T; Hori S; Matsuzaki M; Umezawa H
    J Antibiot (Tokyo); 1971 Mar; 24(3):197-9. PubMed ID: 5551376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution and excretion of aurantin-Cl4 from intact mice and mice with transplantable tumors].
    Suskova VS; Khasigov PZ; Chernov VA; Karpov VL; Serebriakov NG
    Antibiotiki; 1970 May; 15(5):437-41. PubMed ID: 4193821
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of phenomycin, a tumor-inhibitory polypeptide.
    Nishimura T
    J Antibiot (Tokyo); 1968 Feb; 21(2):110-8. PubMed ID: 4877180
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on antitumor antibiotic 1588--IV. Metabolism and toxicity studies].
    Yang GZ
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):5-7. PubMed ID: 6189686
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicological studies on bestatin. I. Acute toxicity test in mice, rats and dogs.
    Sakakibara T; Ito K; Irie Y; Hagiwara T; Sakai Y; Hayashi M; Kishi H; Sakamoto M; Suzuki M; Irie Y
    Jpn J Antibiot; 1983 Nov; 36(11):2971-84. PubMed ID: 6674528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). 3. Toxicological and pharmacological study].
    Julou L; Ducrot R; Fournel J; Ganter P; Maral R; Populaire P; Koenig F; Myon J; Pascal S; Pasquet J
    Arzneimittelforschung; 1967 Aug; 17(8):948-54. PubMed ID: 5632067
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on bleomycin.
    Umezawa H; Ishizuka M; Maeda K; Takeuchi T
    Cancer; 1967 May; 20(5):891-5. PubMed ID: 5337399
    [No Abstract]   [Full Text] [Related]  

  • 8. The distribution of 3H-bleomycin in mouse tissue.
    Umezawa H; Ishizuki M; Hori S; Chimura H; Takeuchi T
    J Antibiot (Tokyo); 1968 Nov; 21(11):638-42. PubMed ID: 4975612
    [No Abstract]   [Full Text] [Related]  

  • 9. The toxicologic evaluation of marcellomycin--an antineoplastic anthracycline antibiotic.
    Buroker RA; Johnson DF; Comereski CR; Hirth RS; Madissoo H; Hottendorf GH
    Drug Chem Toxicol; 1983; 6(1):21-40. PubMed ID: 6861661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin.
    Kratz F; Ehling G; Kauffmann HM; Unger C
    Hum Exp Toxicol; 2007 Jan; 26(1):19-35. PubMed ID: 17334177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the toxicity and pharmacological properties of the new antibiotic lienomycin].
    Filippos'iants ST; Gol'dberg LE; Stepanova ES; Belova IP; Kunrat IA
    Antibiotiki; 1971 Jul; 16(7):604-9. PubMed ID: 5157509
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete amino acid sequence of phenomycin, an antitumor polypeptide antibiotic.
    Muramatsu R; Abe S; Hayashi H; Yamaguchi K; Jinda K; Sakano K; Inouye Y; Nakamura S
    J Antibiot (Tokyo); 1991 Nov; 44(11):1222-7. PubMed ID: 1761418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological study of the antibiotic sibiromycin].
    Iliushina NG; Gol'dberg LE
    Antibiotiki; 1970 Jul; 15(7):612-7. PubMed ID: 4320321
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problem of cumulative properties of the antineoplastic antibiotic 1719].
    Goldberg LE; Filippos'iants ST; Stepanova ES
    Antibiotiki; 1973 Aug; 18(8):701-6. PubMed ID: 4776405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the toxicity and pharmacological properties of beromycin, a new antitumor antibiotic].
    Gol'dberg LE; Filippos'iants ST; Stepanova ES
    Antibiotiki; 1972 Jul; 17(7):616-23. PubMed ID: 4632010
    [No Abstract]   [Full Text] [Related]  

  • 16. [A substance with affinity for malignant cancer, 57Co-bleomycin].
    Kono A; Kojima M; Maeda T
    Rinsho Hoshasen; 1973 Mar; 18(3):195-6. PubMed ID: 4122814
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological studies on formycin and formycin B.
    Ishizuka M; Sawa T; Hori S; Takayama H; Takeuchi T
    J Antibiot (Tokyo); 1968 Jan; 21(1):5-12. PubMed ID: 5673295
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of phenomycin against transplantable animal tumors.
    Nishimura T
    J Antibiot (Tokyo); 1968 Feb; 21(2):106-9. PubMed ID: 5674367
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of the toxicity, pharmacokinetics and pharmacodynamics of the new antitumor antibiotic carminomycin].
    Goldberg LE; Filippos'iants ST; Kunrat IA; Stepanova ES; Shepelevtseva NG
    Antibiotiki; 1974 Jan; 19(1):57-62. PubMed ID: 4463841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Method of determination of cumulative properties of drugs].
    Gol'dberg LE; Baumshteĭn VE
    Farmakol Toksikol; 1969; 32(2):222-6. PubMed ID: 5772152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.